These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32565206)

  • 21. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.
    de Masson A; Bouaziz JD; Sulimovic L; Cassius C; Jachiet M; Ionescu MA; Rybojad M; Bagot M; Duong TA;
    J Am Acad Dermatol; 2020 Aug; 83(2):667-670. PubMed ID: 32380219
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.
    De Giorgi V; Recalcati S; Jia Z; Chong W; Ding R; Deng Y; Scarfi F; Venturi F; Trane L; Gori A; Silvestri F; Gao XH; Lotti T
    J Am Acad Dermatol; 2020 Aug; 83(2):674-675. PubMed ID: 32442696
    [No Abstract]   [Full Text] [Related]  

  • 23. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
    Recalcati S; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak.
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Jul; 83(1):e61-e63. PubMed ID: 32339703
    [No Abstract]   [Full Text] [Related]  

  • 26. SARS-CoV-2-related chilblains.
    Ladha MA; Dupuis EC
    CMAJ; 2020 Jul; 192(28):E804. PubMed ID: 32660940
    [No Abstract]   [Full Text] [Related]  

  • 27. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chilblains in lockdown: An old acquaintance in the context of COVID-19].
    Abril-Pérez C; Sánchez-Arráez J; Roca-Ginés J; Torres-Navarro I
    An Pediatr (Engl Ed); 2020 Jun; 92(6):387-388. PubMed ID: 32402775
    [No Abstract]   [Full Text] [Related]  

  • 29. Case Report: Chilblains-like lesions (COVID-19 toes) during the pandemic - is there a diagnostic window?
    Ludzik J; Witkowski A; Hansel DE; Raess PW; White K; Leachman S
    F1000Res; 2020; 9():668. PubMed ID: 32913640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
    Marzano AV; Cassano N; Genovese G; Moltrasio C; Vena GA
    Br J Dermatol; 2020 Sep; 183(3):431-442. PubMed ID: 32479680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chilblains and COVID19 infection: Causality or coincidence? How to proceed?
    Pistorius MA; Blaise S; Le Hello C; ; Barbarot S; Dréno B
    J Med Vasc; 2020 Jul; 45(4):221-223. PubMed ID: 32571563
    [No Abstract]   [Full Text] [Related]  

  • 32. What Are COVID Toes? A Case Study.
    Beuscher TL; Andrews SE
    J Wound Ostomy Continence Nurs; 2020; 47(6):619-621. PubMed ID: 33201148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient.
    Locatelli AG; Robustelli Test E; Vezzoli P; Carugno A; Moggio E; Consonni L; Gianatti A; Sena P
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e365-e368. PubMed ID: 32386459
    [No Abstract]   [Full Text] [Related]  

  • 34. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
    Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F
    J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180
    [No Abstract]   [Full Text] [Related]  

  • 35. Unraveling the Immune Response in Severe COVID-19.
    Rodriguez L; Brodin P
    J Clin Immunol; 2020 Oct; 40(7):958-959. PubMed ID: 32827284
    [No Abstract]   [Full Text] [Related]  

  • 36. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
    Hughes M; Rogers S; Lepri G; Bruni C; Matucci-Cerinic M
    Br J Dermatol; 2020 Sep; 183(3):596-598. PubMed ID: 32460349
    [No Abstract]   [Full Text] [Related]  

  • 37. Chilblain-like lesions in children following suspected COVID-19 infection.
    Colonna C; Monzani NA; Rocchi A; Gianotti R; Boggio F; Gelmetti C
    Pediatr Dermatol; 2020 May; 37(3):437-440. PubMed ID: 32374033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2.
    Fertitta L; Welfringer-Morin A; Ouedrani A; Polivka L; Chhun S; Chatenoud L; Fourgeaud J; Hadj-Rabia S; Temmam S; Eloit M; Sermet-Gaudelus I; Bodemer C
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e164-e167. PubMed ID: 33010072
    [No Abstract]   [Full Text] [Related]  

  • 39. Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: new insights into the spectrum of clinical presentation and histopathology.
    Ho WYB; Wang D; Tan LYC; Bundele MM; Tan CH; Lim HLJ
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e576-e579. PubMed ID: 32531121
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID toes or pernio?
    Zaladonis A; Huang S; Hsu S
    Clin Dermatol; 2020; 38(6):764-767. PubMed ID: 33341212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.